You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BAXTER HLTHCARE CORP Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?

BAXTER HLTHCARE CORP has sixty-six approved drugs.

There are twenty US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.

There are eight patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and twenty-four supplementary protection certificates in fourteen countries.

Summary for BAXTER HLTHCARE CORP
International Patents:8
US Patents:20
Tradenames:78
Ingredients:52
NDAs:66

Drugs and US Patents for BAXTER HLTHCARE CORP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp NOURESS cysteine hydrochloride SOLUTION;INTRAVENOUS 212535-001 Dec 13, 2019 DISCN Yes No 11,642,370 ⤷  Sign Up Y ⤷  Sign Up
Baxter Hlthcare Corp WYAMINE SULFATE mephentermine sulfate INJECTABLE;INJECTION 008248-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare Corp NOURESS cysteine hydrochloride SOLUTION;INTRAVENOUS 212535-001 Dec 13, 2019 DISCN Yes No 11,510,941 ⤷  Sign Up Y ⤷  Sign Up
Baxter Hlthcare Corp CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 078024-001 Mar 18, 2008 AP RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BAXTER HLTHCARE CORP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 5,013,556 ⤷  Sign Up
Baxter Hlthcare Corp ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 6,900,184 ⤷  Sign Up
Baxter Hlthcare Corp TRANSDERM SCOP scopolamine SYSTEM;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 4,436,741 ⤷  Sign Up
Baxter Hlthcare Corp CLINOLIPID 20% olive oil; soybean oil EMULSION;INTRAVENOUS 204508-001 Oct 3, 2013 5,840,757 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for BAXTER HLTHCARE CORP Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2957286 SPC/GB19/003 United Kingdom ⤷  Sign Up PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTERED: UK EU/1/17/1179/001(NI) 20170721; UK EU/1/17/1179/002(NI) 20170721; UK EU/1/17/1179/003(NI) 20170721; UK EU/1/17/1179/004(NI) 20170721; UK EU/1/17/1179/005(NI) 20170721; UK EU/1/17/1179/006(NI) 20170721; UK EU/1/17/1179/007(NI) 20170721; UK EU/1/17/1179/008(NI) 20170721; UK EU/1/17/1179/009(NI) 20170721; UK PLGB 50784/0002-0001 20170721; UK PLGB 50784/0003-0001 20170721; UK PLGB 50784/0004-0001 20170721
1280520 14/2015 Austria ⤷  Sign Up PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720
0300652 2003C/005 Belgium ⤷  Sign Up PRODUCT NAME: CHLORHYDRATE DE DEXMEDETOMIDINE; REGISTRATION NO/DATE: EU/2/02/033/001 20020903
0206283 SPC/GB97/085 United Kingdom ⤷  Sign Up PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.